Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1981 Feb;67(2):476–485. doi: 10.1172/JCI110056

Prevention of Glomerulonephritis and Prolonged Survival in New Zealand Black/New Zealand White F1 Hybrid Mice Fed an Essential Fatty Acid-deficient Diet

Eric R Hurd 1,2,3,4, John M Johnston 1,2,3,4, Janice R Okita 1,2,3,4, Paul C MacDonald 1,2,3,4, Morris Ziff 1,2,3,4, James N Gilliam 1,2,3,4
PMCID: PMC370589  PMID: 6450777

Abstract

Female B/W mice spontaneously develop an autoimmune disease that is similar to systemic lupus erythematosus. Antibodies to doublestranded DNA (dsDNA) and antinuclear antibodies develop in aging animals; death from immune complex-mediated glomerulonephritis occurs from 8 to 12 mo of age. It has been reported that prostaglandin (PG)E1 treatment of such mice prolongs survival. In the present study, four groups of female B/W mice were studied beginning at 6-11 wk of age on the following regimens: (a) a synthetic diet that contained 20% safflower oil, (b) a standard laboratory chow diet, (c) a standard diet together with injections of PGE1, and (d) an essential fatty acid-deficient synthetic diet that contained 20% coconut oil. All animals were tested monthly for antinuclear antibodies and anti-dsDNA. Kidney tissue was obtained for light and immunofluorescence microscopy when animals were dying. All disease manifestations were altered strikingly in the essential fatty acid (EFA)-deficient animals. Intermediate benefit was seen in PGE1-treated animals. 7% of the control animals and 18% of safflower oil-fed animals survived to 10 mo. In contrast, the PGE1-treated and EFA-deficient mice had a similar survival rate (78-88%). At age 16 mo, 78% of EFA-deficient mice and 45% of PGE1-treated mice were alive. 25% of the PGE1-treated and 55% of the EFA-deficient animals survived to 20 mo. Serum anti-dsDNA appeared at age 5 mo in safflower oil-fed and control animals, but not until 9 and 12 mo for PGE1-treated and EFA-deficient animals, respectively. All kidneys from 7- to 9-mo-old safflower oil-fed and control animals and the majority of kidneys from PGE1-treated animals were abnormal by light and immunofluorescence microscopy. Kidneys from EFA-deficient animals were essentially normal at 10 mo. At 13 mo, all PGE1-treated animals examined had significant kidney involvement, whereas none of the EFA-deficient animals had glomerulonephritis. These findings demonstrate that an EFA-deficient diet has a beneficial effect on murine lupus erythematosus.

Full text

PDF
476

Images in this article

481Image
on p.481
483Image
on p.483

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonta I. L., Chrispijn H., Noordhoek J., Vincent J. E. Reduction of prostaglandin-phase in hind-paw inflammation and partial failure of indomethacin to exert anti-inflammatory effect in rats on essential fatty acid deficient diet. Prostaglandins. 1974 Mar 10;5(5):495–503. doi: 10.1016/s0090-6980(74)80023-7. [DOI] [PubMed] [Google Scholar]
  2. Bonta I. L., Parnham M. J., Adolfs M. J. Reduced exudation and increased tissue proliferation during chronic inflammation in rats deprived of endogenous prostaglandin precursors. Prostaglandins. 1977 Aug;14(2):295–307. doi: 10.1016/0090-6980(77)90175-7. [DOI] [PubMed] [Google Scholar]
  3. Cook J. A., Wise W. C., Callihan C. S. Resistance of essential fatty acid-deficient rats to endotoxic shock. Circ Shock. 1979;6(4):333–342. [PubMed] [Google Scholar]
  4. Cook J. A., Wise W. C., Halushka P. V. Elevated thromboxane levels in the rat during endotoxic shock: protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency. J Clin Invest. 1980 Jan;65(1):227–230. doi: 10.1172/JCI109655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Denko C. W. Modification of adjuvant inflammation in rats deficient in essential fatty acids. Agents Actions. 1976 Sep;6(5):636–641. doi: 10.1007/BF01971583. [DOI] [PubMed] [Google Scholar]
  6. Dubois E. L., Horowitz R. E., Demopoulos H. B., Teplitz R. NZB/NZW mice as a model of systemic lupus erythematosus. JAMA. 1966 Jan 24;195(4):285–289. [PubMed] [Google Scholar]
  7. Dubois E. L., Strain L. Effect of diet on survival and nephropathy of NZB-NZW hybrid mice. Biochem Med. 1973 Apr;7(2):336–342. doi: 10.1016/0006-2944(73)90091-4. [DOI] [PubMed] [Google Scholar]
  8. FOLCH J., LEES M., SLOANE STANLEY G. H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 May;226(1):497–509. [PubMed] [Google Scholar]
  9. Fernandes G., Yunis E. J., Good R. A. Influence of diet on survival of mice. Proc Natl Acad Sci U S A. 1976 Apr;73(4):1279–1283. doi: 10.1073/pnas.73.4.1279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fernandes G., Yunis E. J., Jose D. G., Good R. A. Dietary influence on antinuclear antibodies and cell-mediated immunity in NZB mice. Int Arch Allergy Appl Immunol. 1973;44(6):770–782. doi: 10.1159/000230981. [DOI] [PubMed] [Google Scholar]
  11. Fernandes G., Yunis E. J., Smith J., Good R. A. Dietary influence on breeding behavior, hemolytic anemia, and longevity in NZB mice. Proc Soc Exp Biol Med. 1972 Apr;139(4):1189–1196. doi: 10.3181/00379727-139-36327. [DOI] [PubMed] [Google Scholar]
  12. Gilliam J. N., Hurd E. R., Ziff M. Subepidermal deposition of immunoglobulin in NZB/NZW F hybrid mice. J Immunol. 1975 Jan;114(1 Pt 1):133–137. [PubMed] [Google Scholar]
  13. Goetzl E. J., Sun F. F. Generation of unique mono-hydroxy-eicosatetraenoic acids from arachidonic acid by human neutrophils. J Exp Med. 1979 Aug 1;150(2):406–411. doi: 10.1084/jem.150.2.406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hafiez A. A. Prostaglandin E2 prevents impairment of fertility in rats fed a diet deficient in essential fatty acids. J Reprod Fertil. 1974 Jun;38(2):273–286. doi: 10.1530/jrf.0.0380273. [DOI] [PubMed] [Google Scholar]
  15. Hurd E. R., Gilliam J. N., Ziff M. The differential effects of cyclophosphamide and 6-mercaptopurine on the renal disease and skin immunoglobulin deposits of the NZB-NZW F1 hybrid mice. Agents Actions. 1976 Feb;6(1-3):364–368. doi: 10.1007/BF01972256. [DOI] [PubMed] [Google Scholar]
  16. Jakschik B. A., Falkenhein S., Parker C. W. Precursor role of arachidonic acid in release of slow reacting substance from rat basophilic leukemia cells. Proc Natl Acad Sci U S A. 1977 Oct;74(10):4577–4581. doi: 10.1073/pnas.74.10.4577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Luciano A., Rothfield N. F. Patterns of nuclear fluorescence and DNA-binding activity. Ann Rheum Dis. 1973 Jul;32(4):337–341. doi: 10.1136/ard.32.4.337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. MORRISON W. R., SMITH L. M. PREPARATION OF FATTY ACID METHYL ESTERS AND DIMETHYLACETALS FROM LIPIDS WITH BORON FLUORIDE--METHANOL. J Lipid Res. 1964 Oct;5:600–608. [PubMed] [Google Scholar]
  19. Mason R. J., Stossel T. P., Vaughan M. Lipids of alveolar macrophages, polymorphonuclear leukocytes, and their phagocytic vesicles. J Clin Invest. 1972 Sep;51(9):2399–2407. doi: 10.1172/JCI107052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Meade C. J., Mertin J. Fatty acids and immunity. Adv Lipid Res. 1978;16:127–165. doi: 10.1016/b978-0-12-024916-9.50008-1. [DOI] [PubMed] [Google Scholar]
  21. Mertin J., Hunt R. Influence of polyunsaturated fatty acids on survival of skin allografts and tumor incidence in mice. Proc Natl Acad Sci U S A. 1976 Mar;73(3):928–931. doi: 10.1073/pnas.73.3.928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Parker C. W. Prostaglandins and slow-reacting substance. J Allergy Clin Immunol. 1979 Jan;63(1):1–14. doi: 10.1016/0091-6749(79)90155-6. [DOI] [PubMed] [Google Scholar]
  23. Parnham M. J., Schoester G. A., van der Kwast T. H. Enhancement by prostaglandin E1 and essential fatty acid deficiency of the passive transfer of delayed hypersensitivity to PPD in rats. Comparison with effects on delayed hypersensitivity to SRBC in mice. Int J Immunopharmacol. 1979;1(2):119–126. doi: 10.1016/0192-0561(79)90014-6. [DOI] [PubMed] [Google Scholar]
  24. Robak J., Dembińska-Kieć A., Gryglewski R. The influence of saturated fatty acids on prostaglandin synthetase activity. Biochem Pharmacol. 1975 Nov 15;24(22):2057–2060. doi: 10.1016/0006-2952(75)90102-1. [DOI] [PubMed] [Google Scholar]
  25. Rogers Q. R., Harper A. E. Amino acid diets and maximal growth in the rat. J Nutr. 1965 Nov;87(3):267–273. doi: 10.1093/jn/87.3.267. [DOI] [PubMed] [Google Scholar]
  26. Roubinian J. R., Talal N., Greenspan J. S., Goodman J. R., Siiteri P. K. Delayed androgen treatment prolongs survival in murine lupus. J Clin Invest. 1979 May;63(5):902–911. doi: 10.1172/JCI109390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Roubinian J., Talal N., Siiteri P. K., Sadakian J. A. Sex hormone modulation of autoimmunity in NZB/NZW mice. Arthritis Rheum. 1979 Nov;22(11):1162–1169. doi: 10.1002/art.1780221102. [DOI] [PubMed] [Google Scholar]
  28. Safai-Kutti S., Fernandes G., Wang Y., Safai B., Good R. A., Day N. K. Reduction of circulating immune complexes by calorie restriction in (NZB x NZW) F1 mice. Clin Immunol Immunopathol. 1980 Mar;15(3):293–300. doi: 10.1016/0090-1229(80)90041-0. [DOI] [PubMed] [Google Scholar]
  29. Sontheimer R. D., Gilliam J. N. A reappraisal of the relationship between subepidermal immunoglobulin deposits and DNA antibodies in systemic lupus erythematosus: a study using the Crithidia luciliae immunofluorescence anti-DNA assay. J Invest Dermatol. 1979 Jan;72(1):29–32. doi: 10.1111/1523-1747.ep12530158. [DOI] [PubMed] [Google Scholar]
  30. Stenson W. F., Parker C. W. Monohydroxyeicosatetraenoic acids (HETEs) induce degranulation of human neutrophils. J Immunol. 1980 May;124(5):2100–2104. [PubMed] [Google Scholar]
  31. Turner S. R., Tainer J. A., Lynn W. S. Biogenesis of chemotactic molecules by the arachidonate lipoxygenase system of platelets. Nature. 1975 Oct 23;257(5528):680–681. doi: 10.1038/257680a0. [DOI] [PubMed] [Google Scholar]
  32. Weindruch R. H., Kristie J. A., Cheney K. E., Walford R. L. Influence of controlled dietary restriction on immunologic function and aging. Fed Proc. 1979 May;38(6):2007–2016. [PubMed] [Google Scholar]
  33. Zurier R. B., Damjanov I., Sayadoff D. M., Rothfield N. F. Prostaglandin E1 treatment of NZB/NZW F1 hybrid mice. II. Prevention of glomerulonephritis. Arthritis Rheum. 1977 Nov-Dec;20(8):1449–1456. doi: 10.1002/art.1780200802. [DOI] [PubMed] [Google Scholar]
  34. Zurier R. B., Sayadoff D. M., Torrey A. B., Rothfield N. F. Prostaglandin E treatment of NZB/NZW mice. Arthritis Rheum. 1977 Mar;20(2):723–728. doi: 10.1002/art.1780200213. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES